Dataset opportunity
Zenflow — Medical Imaging Dataset Opportunity
Moderate medical imaging dataset held by Zenflow, usable for Diagnostic AI and Computer Vision.
Score
63.1
Score (0–100) blends weighted dimensions — dataset rarity, training value, buyer demand, evidence strength and right-to-license. 70+ is deal-ready. See the scored dimensions below for the breakdown.Confidence
49%
Action
Data Sharing Agreement
The recommended deal structure for this dataset: Acquire (full buyout), License (paid usage rights), Data Sharing Agreement (controlled access, no transfer of ownership), Partnership (co-development) or Annotation Program (labeling). Chosen from data ownership, licensing complexity and accessibility.Market size (indicative estimate)
Global AI in Medical Imaging market = $1.88 billion in 2025, CAGR 36.91%.
Recent dated external facts that triggered this opportunity — auditable provenance.
- 📰press2026-10-06
Zenflow raises $52M, inks distribution deal with Cook Medical
medtechdive.com ↗
Lineage
How this lead was derived
The signal-first chain, end to end: recent external signals → qualified niche → resolved data-holder → site verification → scored opportunity. Every lead is explainable.
Profile
Dataset profile
Type
Medical Imaging Dataset
Modality
Image
Sector
healthcare
Volume
Moderate
Freshness
Periodic
Rarity
High (proprietary)
Accessibility
Restricted
Legal
Owned by the company — GDPR-sensitive (PII review)
Buyer persona
Medical-AI & diagnostic-imaging companies
Zenflow holds a substantial Medical Imaging Dataset, with image modalities supported by business records, medical records, and regulatory documentation. This curated collection is primed for developing and validating high-precision Diagnostic AI algorithms, offering the rich, multi-faceted data required for robust model training.
The global AI in Medical Imaging market was valued at $1.88 billion in 2025 and is projected to grow at a CAGR of 36.91%. Despite access complexities due to highly sensitive PHI and regulatory constraints like HIPAA, the rarity and quality of this data make it an invaluable asset for buyers seeking a competitive edge in this rapidly expanding market. ⚠ Diligence (valuable data, access to negotiate): Highly sensitive medical and patient health information (PHI); Subject to HIPAA and FDA regulatory constraints; Data is likely siloed within clinical trial management systems · corporate: independent.
Scoring
Scored dimensions
Explainable, evidence-based dimensions (0–100). The radar shows the investment axes.
This evidence collectively proves Zenflow owns a proprietary medical imaging dataset from clinical trials that successfully supported an FDA clearance. This is precisely the type of high-quality, regulatory-grade data sought by medical AI firms to develop and validate diagnostic AI models for conditions like BPH. In a market for AI in medical imaging projected to reach $1.88 billion by 2025, access to such a rare, proprietary dataset offers a significant competitive advantage for building next-generation tools.
See dimension details ↓- Dataset Specificity78
dominant 'medical_records', sector healthcare, 2 specific types
How sharply the data targets a specific, hard-to-substitute domain or task. Niche, well-defined data scores higher than generic. - Dataset Rarity70
proprietary domain data
How scarce and proprietary the data is. Unique domain data scores high; openly available data lowers it. - Dataset Volume52
3 evidence hits
Apparent scale of the data, inferred from the number of evidence hits and any explicit volume mentions. - Dataset Freshness46
periodic
How current the data stays — real-time/streaming scores highest, periodic dumps lower. - Training Value74
fit for Diagnostic AI
How useful the data is for the target AI use-case — its fit for model training or fine-tuning. - Buyer Demand95
Buyer demand is extremely high, driven by the need for high-quality, curated medical imaging data to capitalize on the AI in Medical Imaging market's projected 36.91% CAGR.
How strongly AI builders and companies are likely to want this data, based on market signals. - Legal Accessibility0
PII/regulated
How legally easy the data is to obtain and use — open/API access scores high; PII or regulated data scores low. - Acquisition Feasibility0
high difficulty, independent
How realistic it is to actually obtain the data, given access difficulty and the holder's corporate structure. - Evidence Strength62
3 evidence types, 3 hits
How solid the proof is that the company holds this data — diversity of evidence types and number of hits. - Right to License62
ownership=company_owned, licensing=gdpr_sensitive
Whether the company can legally license the data out — based on ownership and licensing complexity. - Corporate Independence90
independent
Whether the holder can decide alone — an independent company scores higher than a subsidiary of a large group. - Data Orientation22
0 data-appetite signals (0 types)
How actively the company invests in data, measured by its data-appetite signals (hires, products, APIs…). - Dormant Data Surplus92
surplus=high, 1 recent external signals — proprietary data beyond what's already monetised
Volume and value of proprietary data this company holds BEYOND what it already monetises — the dormant surplus we can unlock. A company can sell some insights AND still sit on a far larger dormant asset. - ICP Audit100
✓ good target — Zenflow is an ideal target as it is an SME that manufactures a physical medical device and, as a by-product of extensive clinical trials, holds valuable, proprietary clinical outcome data which it does not currently sell. Issues: The company's core business is manufacturing and selling the 'Spring System', a physical medical device for treating BPH, with a distribution agreement through ; The proprietary data is generated from extensive clinical trials (e.g., ZEST, BREEZE) and includes long-term patient outcomes, symptom scores, and quality of li; The company is a small enterprise with employee counts estimated between 25 and 50. [1, 4, 8, 10]; There is name confusion with unaffiliated companies, notably 'Zenflow by Zencoder' (an AI coding tool) and 'Zenflow Pvt. Ltd.' (a SaaS developer in India), whic
- Deep Qualification90
✓ pass — Zenflow is a strong data holder candidate. It sells an FDA-approved medical device for BPH, and as a byproduct of its extensive clinical trials (ZEST, BREEZE), it owns a valuable dataset including patient outcomes and likely medical imaging, which is highly coherent with the initial hypothesis.
Evidence
Dataset evidence & lineage
What the typed evidence proves the company holds — reframed for clarity and set against the market.
Medical records / imaging
This evidence indicates the dataset contains images sourced from independent clinical studies, providing the clinically-validated data essential for training AI models on real-world patient outcomes.
Regulatory records
This confirms the dataset's data was robust enough to support a successful FDA clearance, making it a gold-standard asset that de-risks development for AI companies seeking their own future regulatory scrutiny.
business_records
Business records provide clear commercial context, linking the data directly to a specific medical device (the Spring System) and demonstrating its product-level specificity for a well-defined diagnostic area.
Marketplace
Dataset details
Detailed schema & sample available on access request.
Want this data?
Request access — we broker a secure deal room. Operator-reviewed, no automatic sharing.
This listing was generated automatically from public signals. It is not verified, and we are not affiliated with this company.
Coverage
Scanned sources
Deliverable
Premium dataset report
Zenflow Medical Imaging — a Moderate medical imaging dataset (Image modality) in the healthcare domain. Primary AI use-case: Diagnostic AI. Market signal: Global AI in Medical Imaging market = $1.88 billion in 2025, CAGR 36.91% (source: Fortune Business Insights). Investment score 63.1/100 (confidence 0.49). Recommended action: Data Sharing Agreement.
From the marketplace
Explore live data opportunities
Ensoma — Medical Imaging Dataset Opportunity
View opportunity →healthcareSomatechnology — Maintenance Logs Dataset Opportunity
View opportunity →healthcarePfmmedical — Medical Imaging Dataset Opportunity
View opportunity →Data Academy
Learn before you deal
- How a Data Transaction Works3 min read
- What you are entitled to sell3 min read
- 5 Mistakes That Drive Buyers Away3 min read